Kelly R. Thornburg
Corporate Officer/Principal bei CHIMERIC THERAPEUTICS LIMITED
Aktive Positionen von Kelly R. Thornburg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03.02.2022 | - |
Karriereverlauf von Kelly R. Thornburg
Ehemalige bekannte Positionen von Kelly R. Thornburg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XBIOTECH INC. | Geschäftsführer | 08.06.2015 | 05.05.2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Ausbildung von Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Australien | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Börse
- Insiders
- Kelly R. Thornburg
- Erfahrung
